Catalyst Wire Dossier Catalyst Wire Dossier

ACP-001 (TransCon PEG hGH)

TransCon PEG hGH · Ascendis Pharma A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACP-001 (TransCon PEG hGH), covering 2010-06-08 to 2010-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH) [Phase 1]

See pricing